Clinical Test for Transtek Glass Body Analyzer
GBA
Verify the Functions and Efficiency of Transtek Glass Body Analyzer, GBF-830, GBF-835, GBF-950, SA-15
2 other identifiers
observational
74
1 country
1
Brief Summary
The clinical protocol of the clinical testing of this device:
- 1.Objective of the test: To verify the functions and efficiency of devices.
- 2.Test methods and procedures: Comparison Test.
- 3.DUT: Transtek Glass Body Analyzer, Model: GBF-830, GBF-835, GBF-950, and SA-15.
- 4.Comparison device: Scaleman Body Fat Scales, FS-148BW1 (Predicate Device).
- 5.Study endpoints: Transtek devices and the predicate device are substantial equivalence.
- 6.Statistical methodology used: Description of statistical methods.
- 7.Result: Efficiencies of Transtek devices and predicate device are in the same level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 12, 2011
CompletedFirst Posted
Study publicly available on registry
February 15, 2011
CompletedDecember 23, 2011
December 1, 2011
1 month
February 12, 2011
December 22, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Verify the accuracy of measure functions of device
Verify the functions and efficiency of these devices compare with a specified product.
10 days
Study Arms (1)
Body Analysis
Interventions
Scaleman Body Fat Scales, FS-148BW1, accuracy: ±0.1kg and range: 0-180kg.
Eligibility Criteria
The subject population included patients whose age is above 18 years old. Male or Female.
You may qualify if:
- male,female
You may not qualify if:
- below 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Leo Wanglead
- West China Hospitalcollaborator
Study Sites (1)
Wuhou District Hospital
Chengdu, Sichuan, 610041, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guoqing Li, Director
Wuhou District Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Team Leader
Study Record Dates
First Submitted
February 12, 2011
First Posted
February 15, 2011
Study Start
November 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
December 23, 2011
Record last verified: 2011-12